ICD-10 Coding for Non-Small Cell Lung Carcinoma(C34.0, C34.11U, C34.90)
Explore ICD-10 coding guidelines for non-small cell lung carcinoma, including specific histology codes and documentation requirements.
Complete code families applicable to Non-Small Cell Lung Carcinoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung | Use when NSCLC is diagnosed without further specification of histology or laterality. |
|
| M8012/3 | Large cell carcinoma | Use when histopathology specifies large cell carcinoma. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutNon-Small Cell Lung Carcinoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Non-Small Cell Lung Carcinoma.
Omitting laterality in documentation
Impact
Clinical: May affect treatment decisions., Regulatory: Non-compliance with coding standards., Financial: Potential for reduced reimbursement.
Mitigation
Always document laterality in clinical notes., Verify imaging reports for laterality.
Coding NSCLC as unspecified when histology is known
Impact
Reimbursement: May lead to lower reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Decreased accuracy in cancer registry data.
Mitigation
Use specific histology codes when available.
Histology documentation
Impact
Failure to document specific histology can lead to audit issues.
Mitigation
Ensure pathology reports are detailed and included in patient records.